Edgewise Therapeutics (EWTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov18

Evercore ISI Analyst Maintains Buy Rating on Edgewise Therapeutics

10:42

Nov14

JP Morgan Raises Target Price, Driving Edgewise Therapeutics Stock Up

17:29

Nov13

Piper Sandler Analyst Maintains Buy Rating for Edgewise Therapeutics

11:52

Nov7

H.C. Wainwright Reiterates Buy Rating on Edgewise Therapeutics

12:02

Nov6

Edgewise Therapeutics released FY2025 Q3 earnings on November 6, Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.39 (forecast USD -0.3932)

14:30

Edgewise Therapeutics released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 0, actual EPS USD -1.1584

14:30

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -40.67 M, EPS -0.3854

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -36.12 M, EPS -0.3441

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -40.8 M, EPS -0.4288

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change